Concepedia

Wei Lou

WL

86

Publications

6.5K

Citations

49

H-Index

1995

Active since

Affiliations

University of California, Davis(Current)

VA Northern California Health Care System

Roswell Park Comprehensive Cancer Center

UC Davis Comprehensive Cancer Center

Johns Hopkins University

Wei Lou is an author at University of California, Davis specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1995–2024

86

Publications

86

Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Clinical Cancer Research · 2014 · 351 citations · Full text

Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway

Wei Lou, Zuyao Ni, Kevin F. Dyer et al. · The Prostate · 2000 · 278 citations

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Cancer Research · 2015 · 239 citations · Full text

, , +11

Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.

Zhaohui Ni, Wei Lou, Eddy S. Leman et al. · PubMed · 2000 · 211 citations

, , +16

CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13.

Allen C. Gao, Wei Lou, Jin‐Tang Dong et al. · PubMed · 1997 · 197 citations

, , +14

Rows per page

1–5 of 86